Review of Pharmacological Activity of Ephedra Gerardiana
Abstract
![](/public/site/graph.png)
Ephedra gerardiana (E. gerardiana,), commonly known as "Ma-huang," is a medicinal plant native to the Himalayan region. Historically, it has a long traditional use in various indigenous systems for medicinal purpose. The current review aims to summarize the present knowledge on the botanical description, phytochemistry, traditional uses, and pharmacological properties of E. gerardiana. This study was thoroughly based on previous literature and was conducted by using electronic databases such as PubMed, Scopus, and Google Scholar. Relevant studies and recently published articles up till 2020 were included in this review. E. gerardiana is a small shrub-like plant characterized by jointed stems, scale-like leaves, and cylindrical cones. It belongs to the family Ephedraceae and is commonly found in arid and semi-arid regions. Phytochemical analysis has revealed the presence of various bioactive compounds in Ephedra gerardiana, including ephedrine, pseudoephedrine, norephedrine, and methyl ephedrine. These alkaloids are primarily responsible for their pharmacological activities. In traditional medicine, Ephedra gerardiana has been used for its bronchodilatory, diaphoretic, diuretic, and thermogenic properties. Additionally, it has been employed for the treatment of respiratory disorders, namely, asthma and nasal congestion, as a stimulant. Its bioactive alkaloids, particularly ephedrine, have been extensively studied for their potential therapeutic applications. However, caution should be exercised due to the potential side effects associated with ephedrine-containing products. Further research can explore its mechanisms of action, optimize dosage regimens, and investigate potential drug interactions to ensure its safe and effective use in clinical settings.
Downloads
References
Zhang B-M, Zhi-Bin W, Ping X, Qiu-Hong W, He B, Kuang H-X. Phytochemistry and pharmacology of genus Ephedra. Chin J Nat Med. 2018;16(11):811–828. https://doi.org/10.1016/S1875-5364(18)30123-7
González-Juárez DE, Escobedo-Moratilla A, Flores J, et al. A review of the Ephedra genus: distribution, ecology, ethnobotany, phytochemistry and pharmacological properties. Molecules. 2020;25(14):e3283. https://doi.org/10.3390/molecules25143283
Chaudhary MK, Misra A, Srivastava S. Evaluation of ephedrine content and identification of elite chemotype (s) of Ephedra gerardiana (Wall.) from Kashmir Himalayas. Proc National Acad Sci Ind Sec Biol Sci. 2020;90(4):833–841. https://doi.org/10.1007/s40011-019-01153-2
Kurosawa W, Kan T, Fukuyama T. Stereocontrolled total synthesis of (−)-ephedradine A (orantine). J Am Chem Soc. 2003;125(27):8112–8113. https://doi.org/10.1021/ja036011k
Zhu J, Hesse M. The spermine alkaloids of chaenorhinum minus. Planta Med. 1988;54(05):430–433. https://doi.org/10.1055/s-2006-962490
Hikino H, Kiso Y, Ogata M, et al. Pharmacological actions of analogues of feruloylhistamine, an imidazole alkaloid of ephedra roots1. Planta Med. 1984;50(06):478–480. https://doi.org/10.1055/s-2007-969777
Krizevski R, Bar E, Shalit O, Sitrit Y, Ben-Shabat S, Lewinsohn E. Composition and stereochemistry of ephedrine alkaloids accumulation in Ephedra sinica Stapf. Phytochemistry. 2010;71(8–9):895–903. https://doi.org/10.1016/j.phytochem.2010.03.019
Ballero M, Foddis C, Sanna C, et al. Pharmacological activities on Ephedra nebrodensis Tineo. Nat Product Res. 2010;24(12):1115–1124. https://doi.org/10.1080/14786410802680902
Groves RA, Hagel JM, Zhang Y, et al. Transcriptome profiling of khat (Catha edulis) and Ephedra sinica reveals gene candidates potentially involved in amphetamine-type alkaloid biosynthesis. PLoS One. 2015;10(3):e0119701. https://doi.org/10.1371/journal.pone.0119701
Hikino H, Konno C, Takata H, Tamada M. Antiinflammatory principle of Ephedra herbs. Chem Pharmac Bull. 1980;28(10):2900–2904. https://doi.org/10.1248/cpb.28.2900
Krizevski R, Bar E, Shalit O, et al. Benzaldehyde is a precursor of phenylpropylamino alkaloids as revealed by targeted metabolic profiling and comparative biochemical analyses in Ephedra spp. Phytochemistry. 2012;81:71–79. https://doi.org/10.1016/j.phytochem.2012.05.018
Zhang D, Deng A-J, Ma L, et al. Phenylpropanoids from the stems of Ephedra sinica. J Asian Nat Pro Res. 2016;18(3):260–267. https://doi.org/10.1080/10286020.2015.1070831
Starratt AN, Caveney S. Quinoline-2-carboxylic acids from Ephedra species. Phytochemistry. 1996;42(5):1477–1478. https://doi.org/10.1016/0031-9422(96)00126-4
Nawwar M, Barakat H, Buddrust J, Linscheidt M. Alkaloidal, lignan and phenolic constituents of Ephedra alata. Phytochemistry. 1985;24(4):878–879. https://doi.org/10.1016/S0031-9422(00)84920-1
Tamada M, Endo K, Hikino H. Maokonine, hypertensive principle of Ephedra Roots1. Planta Medica. 1978;34(07):291–293. https://doi.org/10.1055/s-0028-1097453
Zhao W, Deng A-J, Du G-H, Zhang J-L, Li Z-H, Qin H-L. Chemical constituents of the stems of Ephedra sinica. J Asian Nat Prod Res. 2009;11(2):168–171. https://doi.org/10.1080/10286020802573552
Khan IA, Abourashed EA. Leung's Encyclopedia of Common Natural Ingredients: Used In Food, Drugs And Cosmetics. John Wiley & Sons; 2011.
Shuang-Man M, Zhang Q, Xiao-Bao B, Jin-Long C, Meng-Liang W. A review of the phytochemistry and pharmacological activities of Ephedra herb. Chinese journal of natural Medicines. 2020;18(5):321–344. https://doi.org/10.1016/S1875-5364(20)30040-6
Nawwar MA, El-Sissi HI, Barakat HH. Flavonoid constituents of Ephedra alata. Phytochemistry. 1984;23(12):2937–2939. https://doi.org/10.1016/0031-9422(84)83045-9
Amakura Y, Yoshimura M, Yamakami S, et al. Characterization of phenolic constituents from Ephedra herb extract. Molecules. 2013;18(5):5326-5334. https://doi.org/10.3390/molecules18055326
Pechini MP. Washington, DC: US patent and trademark office. US patent. 1967(3.330):697.
Bouchard NC, Howland MA, Greller HA, Hoffman RS, Nelson LS. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. InMayo Clinic Proc. 2005;80(4):541–545. https://doi.org/10.4065/80.4.541
Cottiglia F, Bonsignore L, Casu L, et al. Phenolic constituents from Ephedra nebrodensis. Nat Product Res. 2005;19(2):117–123. https://doi.org/10.1080/14786410410001704714
Purev O, Pospíšil F, Motl O. Flavonoids from Ephedra sinica stapf. Collection Czechoslovak Chem Commun. 1988;53(12):3193–3196. https://doi.org/10.1135/cccc19883193
Porter PL, Wallace JW. C-glycosylflavones from species of Ephedra. Biochem Syst Ecol. 1988;16(3):261–262. https://doi.org/10.1016/0305-1978(88)90003-8
Wallace JW. C‐Glycosylflavones in the gnetopsida: A preliminary report. Am J Botany. 1979;66(3):343–346. https://doi.org/10.1002/j.1537-2197.1979.tb06233.x
Ohba S, Yoshida K, Kondo T. Swertisin dihydrate. Crystal Struc Commun. 2004;60(12):o893–o896. https://doi.org/10.1107/S0108270104028355
Hussein SA, Barakat HH, Nawar MA, Willuhn G. Flavonoids from Ephedra aphylla. Phytochemistry. 1997;45(7):1529–1532. https://doi.org/10.1016/S0031-9422(97)00092-7
Friedrich H, Wiedemeyer H. Quantitative bestimmung der gerbstoffbildner und der gerbstoffe in ephedra helvetica. Planta Medica. 1976;30(07):223–231. https://doi.org/10.1055/s-0028-1097722
Tao H, Wang L, Cui Z, Zhao D, Liu Y. Dimeric proanthocyanidins from the roots of ephedra sinica. Planta Med. 2008;74(15):1823–1825. https://doi.org/10.1055/s-0028-1088321
Hikino H, Shimoyama N, Kasahara Y, Takahashi M, Konno C. Structures of mahuannin A and B, hypotensive principles of Ephedra roots. Heterocycles. 1982;19(8):1381–1384.
Tao H, Wang L, Cui Z. Study on chemical constituents of root of Ephedra sinica [J]. Chin Tradit Herb Drugs. 2010;41(4):533–536.
Zang X, Shang M, Xu F, et al. A-type proanthocyanidins from the stems of Ephedra sinica (Ephedraceae) and their antimicrobial activities. Molecules. 2013;18(5):5172–5189. https://doi.org/10.3390/molecules18055172
Ibragic S, Sofić E. Chemical composition of various Ephedra species. Bosnian J Basic Med Sci. 2015;15(3):21–27. https://doi.org/10.17305/bjbms.2015.539
Uttra AM, Shahzad M, Shabbir A, Jahan S. Ephedra gerardiana aqueous ethanolic extract and fractions attenuate Freund Complete Adjuvant induced arthritis in Sprague Dawley rats by downregulating PGE2, COX2, IL-1β, IL-6, TNF-α, NF-kB and upregulating IL-4 and IL-10. J Ethnopharma. 2018;224:482–496. https://doi.org/10.1016/j.jep.2018.06.018
Copyright (c) 2023 Halima Nazar, Azalfa Amar, Mohmmad Younus, Ghazala Shaheen, Hafiz Muhammad Asif, Farah Zafar, Sultan Ayaz
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.